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1. Introduction 
In a series of publications from this laboratory the 
nature of sterol and steroid hormone metabolites in 
feces from man [l-5] and animals (for references, 
see [6]) has been described. From studies in germfree 
and conventional rats the profound influence of inte- 
stinal bacteria on steroid metabolism has been de- 
monstrated [7]. It has also been shown that in man 
sterol metabolizing microorganisms in the intestinal 
tract become active within the first year of life [4] 
and that the pattern of steroid hormone metabolites 
excreted in feces undergoes marked changes during 
the first six months after birth [S] . In connection 
with these studies an investigation of the steroid com- 
position in meconium was initiated. During this study 
a great number of Cl9 and C2, steroids and consider- 
able amounts of monohydroxy (C2701) and dihydroxy 
(C2702) sterols have been found in the steroid mono- 
sulphate fraction. This communication deals primarily 
with the identification of the dihydroxy compounds. 
2. Materials and Methods 
Meconium from newborns, delivered without com- 
plications after normal pregnancies, was collected dur- 
ing the first 24 hours after birth and was stored at 
-20” until analyzed. Meconium, 30 g, was extracted 
twice with 200 ml of chloroform/methanol, 1: 1 (v/v), 
and once with 200 ml of ethanol. After evaporation 
of the solvents the extract was partitioned between 
100 ml of petroleum ether and 100 ml of aqueous 
ethanol (3:7, v/v). The ethanol phase was passed 
through a 10 g column of Amberlyst-15 (Rohm and 
Haas Co., Philadelphia, Pa., USA) in the sodium form. 
The solvent was evaporated and the residue was 
chromatographed on a 40 g column of Sephadex 
LH-20 using chloroform/methanol (1: 1, v/v) contain- 
ing 0.0 1 moles/ 1 of sodium chloride as the mobile 
phase [8]. Fractions of 10 ml were collected. An 
added tracer amount of the sodium salt of 3phydroxy- 
androstd-en-17-one-70-[3H]-sulphate was eluted be 
tween 300 and 450 ml. When 500 ml had been eluted 
the column was rinsed with 500 ml of methanol form- 
ing the “disulphate fraction”. 
The fractions eluted between 300 and 450 ml were 
separately taken to dryness. Each residue was dis- 
solved in 5 ml of 2M H2S0, and immediately ex- 
tracted three times with 50 ml of ethylacetate. The 
ethylacetate phases were combined, left on a water 
bath at 39” overnight under shaking, and then washed 
with 6 ml portions of 8.4% sodium bicarbonate until 
alkaline and with 6 ml portions of water until neutral. 
The solvent was evaporated and the residue chromato- 
graphed on a 200 mg column of silicic acid (Mallinc- 
krodt, St. Louis, MO., USA) in benzene. After elution 
with 6 ml of benzene/ethyl acetate (95:5, v/v) (frac- 
tion I), the columns were eluted with 6 ml of benzene/ 
ethyl acetate (7:3, v/v) (fraction II), and 6 ml of ethyl 
acetate (fraction III). The steroids in fractions I-III 
were analyzed as their trimethylsilyl (silyl) ether deri- 
vatives with an LKB 9000 Gas Chromatograph - Mass 
Spectrometer, using 1% SE-30 and 3% QF-1 columns. 
The temperature of the molecule separator and the 
ion source were 260” and 290°, respectively. The en- 
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Fig. 1. Total ion current recording obtained in the gas chroma- 
tography-mass pectrometry analysis of trimethylsilyl (TMS) 
ethers of solvolyzable steroids in the monosulphate fraction 
from meconium. The compounds giving peaks A, C, D and E 
are C, sterols whereas the peaks appearing before peak A re- 
present Cta and Car steroids. Column: 3m X. 3.2 mm, 1% 
SE-30 on Gas-Chrom Q 80- 100 mesh. Column temperature: 
230°. Carrier gas: helium. 
ergy of the bombarding electrons was 22.5 eV and 
the ionizing current was 60 a. 
3. Results 
Fig. 1 shows the result of a gas chromatography 
analysis of a solvolyzed pool of aliquots of the frac- 
tions eluted between 280 and 450 ml of solvent from 
the Sephadex LH-20 column. None of the peaks in 
this chromatogram were found when gas chromato- 
graphy analysis was made prior to solvolysis. Table 1 
shows the retention times of the silyl ether derivatives 
of the C27 sterols shown in fig. 1 and those of the 
appropriate reference compounds. Lathosterol and 
26-hydroxycholesterol were found in a few of the 
separately analyzed monosulphate fractions but not 
in the pooled sample. 
With one exception the identifications suggested in 
table 1 were based on comparisons with mass spectra 
of authentic compounds. Thus the 22- and 24hydroxy- 
cholesteryl silyl ethers yielded molecular ions at m/e 
546 (compounds C and E, see table 1) and could be 
easily recognized by their side chain fragmentation 
[9 ] . The base peaks in the mass spectra of 22- and 24 
hydroxycholesteryl silyl ethers are found at m/e 173 
(tentative structure: (CH$,Si-6 = CH-CHZ-CHZ- 
CH(CH,),) and at m/e 14.5 (tentative structure: 
(CH,),Si-b = CH-CH(CH,),), respectively. 
The molecular ion recorded for compound D at 
m/e 546 indicated a dihydroxysterol structure. The 
position of a hydroxyl group in the side chain of chol- 
esterol could be deduced by assuming that the base 
peak at m/e 159 was formed by a fragmentation ana- 
logous to that occurring in compounds C and E. The 
ion at m/e !59 would then have the tentative structure: 
(CH,),Si-0 = CH-CHZ-CH(CH&. This interpreta- 
tion is further supported by the presence of a base 
peak at m/e 157 in the mass spectrum of the silyl ether 
derivative of the 23(S) isomer of the recently charac- 
terized 23(f)-hydroxylanosterol [lo] . Hydrogenation 
of this compound in ethanol with 1% Pd on charcoal 
followed by silylation led to the disappearance of the 
m/e 157 peak. A new base peak was found at m/e 
159. The ions mentioned are believe! to have the fol- 
lowing structures: 157 = (CH )3Si-0 = CH-CH = 
CH(CH3)2; 159 = (CH3)3Si- ‘b = CH-CH,-. 
CH(CH3)2. Thus, compound D is tentatively identified 
as 23-hydroxycholesterol. Furthermore, the silyl ether 
of compound D also gives a peak at m/e 489 (M-57), 
probably formed by loss of the fragment: CHZ- 
CH(CH,),. An analogous fragmentation of the side 
chain occurs in the silyl ether derivatives of 24 and 22- 
hydroxycholesterol yielding peaks at m/e 503 (M-43) 
and m/e 475 (M-7 1) respectively. The ion of mass 173 
in the mass spectrum of the silyl ether of compound D 
could arise through cleavage of the C2 1 -C22 bond and 
is probably analogous to the peak at m/e 159 in the 
mass spectrum of 24hydroxycholesteryl silyl ether. 
The designation 22(S)-hydroxycholesterol (com- 
pound C; see table 1) was made on the basis of gas 
chromatography data. The stereochemistry of 23- and 
24hydroxycholesterol could not be determined be- 
cause of lack of the appropriate reference substances. 
Cholesterol and lathosterol but no other C2,01 or 
plant sterol were found in silicic acid column fraction 1 
A small amount of C2702 sterols was also present in 
this fraction but these sterols were mainly found in 
fraction II from which 26hydroxycholesterol was 
isolated and identified. More polar sterols than those 
described in this report appeared in fractions II and III 
and are currently under investigation. 
Small amounts of C2702 sterols were liberated 
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Table 1 
Retention times relative to cholesterol (r~) of the trimethylsilyl ethers of solvolizable Cz7 sterols in meconium and the corres 
ponding authentic compounds. 
Compound in 
meconium* 
tR Authentic compound rR 
SE-30 QF-1 SE-30 QF-1 
Compound A 1.26 0.71 Cholesterol** 1.26 0.71 
Compound B 1.44 0.79 Lathosterol** 1.44 0.79 
Compound C 2.00 1.00 22(S)-Hydroxycholesterol 1.99 1.00 
22(R)-Hydroxycholesterol 1.92 1.00 
Compound D 2.19 1.13 
Compound E 2.58 1.33 24(R)-Hydroxycholesterol 2.59 1.32 
Compound F 3.15 1.55 26-Hydroxycholesterol 3.15 1.56 
* Compounds A, C, D and E are represented by peaks in the chromatogram shown in fig. 1, whereas compounds B and F could 
only be found after careful silicic acid column fractionation. 
** The systematic names of cholesterol and lathosterol are cholest-S-en-3@ol and 5cr-cholest-7-en-30-01, respectively. 
upon solvolysis of the “disulphate fraction” from the 
Sephadex LH-20 chromatography whereas no hydroxy- 
sterols could be detected in the unesterified sterol 
fraction. 
4. Discussion 
Chromatography and solvolysis data strongly in- 
dicate that the sterols identified occur in meconium 
as monosulphates and to a small extent as disulphates. 
The most important CT702 sterol in the monosul- 
phate fraction was 22(S)-hydroxycholesterol in con- 
trast to the finding in feces from children up to one 
year of age in which 24hydroxycholesterol was the 
most abundant hydroxycholesterol compound [9]. 
This is of interest since the newborn has a hyper- 
trophic adrenal cortex which gradually disappears 
during the first year of life and in view of the impor- 
tance of hydroxylation at C22 in the conversion of 
cholesterol to pregnenolone [ 111. The 22(S)-hydroxy- 
cholesterol sulphate in meconium may represent a step 
in the conversion of cholesteryl sulphate to C21.steroid 
sulphates [12,13]. 
No 23-hydroxylated neutral sterol or bile alcohol 
has hitherto been found in animals but bile alcohols 
with a 22- or 24hydroxyl group and bile acids with a 
22-, 23- or a 24-hydroxyl group are known to be pres- 
ent in amphibian and reptile bile [ 141. In higher ani- 
mals bile acid biosynthesis seems to involve 24 and 
26-hydroxylated precursors (ref. 1.5 and 16 respecti- 
vely). The presence of comparatively large amounts of 
side chain hydroxylated cholesteryl sulphates in human 
meconium may thus reflect an incomplete or immature 
bile acid synthesis. In fact, low bile acid concentra- 
tions have been found in human meconium [ 171 indi- 
cating a poor bile acid synthesis in the liver [ 181. So 
far, however, no sulphurylated intermediate has been 
postulated in animal bile acid synthesis. Thus 
26[ 14C] -cholesterol but not 26-[ 14C] -cholesteryl sul- 
phate was oxidized to 14C02 by mouse liver mito- 
chondria in vitro [ 191. Palmer on the other hand has 
isolated 3esulphates of glycolithocholic and tauro- 
lithocholic acids in human bile [20] , indicating that 
the synthesis and/or metabolism of bile acids is not 
yet fully known. 
Apparently the metabolic significance of the hy- 
droxycholesteryl sulphates identified in this and a 
previous report remains unknown [9]. Further work 
is needed to establish whether they are intermediates 
in the degradation of the side chain or represent end 
or side products of cholesterol catabolism. 
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